Wine: Does the colour count?

被引:42
作者
Goldberg, DM [1 ]
GarovicKocic, V [1 ]
Diamandis, EP [1 ]
PaceAsciak, CR [1 ]
机构
[1] HOSP SICK CHILDREN,RES INST,TORONTO,ON M5G 1X8,CANADA
关键词
wine; coronary heart disease; plasma lipids; lipoproteins; flavonoids; polyphenols; HDL-cholesterol;
D O I
10.1016/0009-8981(96)06229-8
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The objective of this study was to determine whether phenolic constituents present in red wine and grape juice modulate plasma lipid and lipoprotein concentrations in healthy human subjects. All subjects consumed in random order 375 ml of red or white wine per day or 500 ml of two different grape juices (high and low phenols) per day for periods of 4 weeks separated by 2-week periods of abstention while continuing normal activity and food intake, and their normal lives in a community setting. The subjects were 24 healthy males aged 26-45 years screened by clinical examination and laboratory tests to exclude hypertension, diabetes mellitus, hyperlipidemia and obesity, among others. Fasting blood was collected at the beginning and end of each beverage schedule for analysis of lipids and lipoproteins. Changes in plasma lipids and lipoproteins in response to each beverage were measured to determine whether these were altered by red wine and grape juice phenolics independently of the effects of ethanol. Both grape juices had virtually no effect. Red and white wines raised plasma HDL-cholesterol and apo A-I and apo A-II concentrations as well as the apo A-I:apo B ratio to a similar extent, Red wine also raised plasma triglyceride and total cholesterol concentrations. Neither wine affected plasma apo B or apo (a) concentrations. The favourable effects of wines in modulating plasma lipid and lipoprotein concentrations are probably due to their alcohol content and cannot be reproduced by grape juices.
引用
收藏
页码:183 / 193
页数:11
相关论文
共 41 条
[21]   DIFFERENTIAL-EFFECTS OF ALCOHOLIC BEVERAGES ON EXPERIMENTAL ATHEROSCLEROSIS IN RABBITS [J].
KLURFELD, DM ;
KRITCHEVSKY, D .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1981, 34 (01) :62-71
[22]   LIPOPROTEINS AND BLOOD-PRESSURE AS BIOLOGICAL PATHWAYS FOR EFFECT OF MODERATE ALCOHOL-CONSUMPTION ON CORONARY HEART-DISEASE [J].
LANGER, RD ;
CRIQUI, MH ;
REED, DM .
CIRCULATION, 1992, 85 (03) :910-915
[23]  
LAPORTE R, 1981, CIRCULATION, V64, P67
[24]   EFFECT OF ALCOHOL INTAKE ON HIGH AND LOW-DENSITY LIPOPROTEIN METABOLISM IN HEALTHY-VOLUNTEERS [J].
MALMENDIER, CL ;
DELCROIX, C .
CLINICA CHIMICA ACTA, 1985, 152 (03) :281-288
[25]   RED WINE AND ANTIOXIDANT ACTIVITY IN SERUM [J].
MAXWELL, S ;
CRUICKSHANK, A ;
THORPE, G .
LANCET, 1994, 344 (8916) :193-194
[26]   EFFECT OF LOW-DOSE ALCOHOL-USE VERSUS ABSTENTION ON APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B [J].
MOORE, RD ;
SMITH, CR ;
KWITEROVICH, PO ;
PEARSON, TA .
AMERICAN JOURNAL OF MEDICINE, 1988, 84 (05) :884-890
[27]   THE RED WINE PHENOLICS TRANS-RESVERATROL AND QUERCETIN BLOCK HUMAN PLATELET-AGGREGATION AND EICOSANOID SYNTHESIS - IMPLICATIONS FOR PROTECTION AGAINST CORONARY HEART-DISEASE [J].
PACEASCIAK, CR ;
HAHN, S ;
DIAMANDIS, EP ;
SOLEAS, G ;
GOLDBERG, DM .
CLINICA CHIMICA ACTA, 1995, 235 (02) :207-219
[28]   Wines and grape juices as modulators of platelet aggregation in healthy human subjects [J].
PaceAsciak, CR ;
Rounova, O ;
Hahn, SE ;
Diamandis, EP ;
Goldberg, DM .
CLINICA CHIMICA ACTA, 1996, 246 (1-2) :163-182
[29]   WINE, ALCOHOL, PLATELETS, AND THE FRENCH PARADOX FOR CORONARY HEART-DISEASE [J].
RENAUD, S ;
DELORGERIL, M .
LANCET, 1992, 339 (8808) :1523-1526
[30]  
Rifai N, 1994, Laboratory measurement of lipids, lipoproteins and Apolipoproteins